Клінічне значення тестикулярного мікролітіазу та визначення нових маркерів при герміногенних пухлинах яєчка
##plugins.themes.bootstrap3.article.main##
Анотація
##plugins.themes.bootstrap3.article.details##
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Автори зберігають авторське право, а також надають журналу право першого опублікування оригінальних наукових статей на умовах ліцензії Creative Commons Attribution 4.0 International License, що дозволяє іншим розповсюджувати роботу з визнанням авторства твору та першої публікації в цьому журналі.
Посилання
Richenberg J. Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee / J. Richenberg, J. Belfield, P. Ramchandani [et al.] // Eur. Rad. – 2015. – P. 323–330. https://doi.org/10.1007/s00330-014-3437-x
Pedersen M. Testicular microlithiasis and testicular cancer: review of the literature / M. Pedersen, S. Rafaelsen, H. Moller [et al.] // Int. Urol. Nephrol. – 2016. – 7. – P. 1079–86. https://doi.org/10.1007/s11255-016-1267-2
Miller F.N. Does testicular microlithiasis matter? A review / F.N. Miller [et al.] // Clin. Radiol. – 2002. – 57. – P. 883–90. https://doi.org/10.1053/crad.2002.1005
Nord C. Gonadal hormones in long term survivors 10 years after treatment for unilateral testicular cancer / C. Nord [et al.] // Eur. Urol. – 2003. – 322–8. https://doi.org/10.1016/S0302-2838(03)00263-X
Gilligan TD. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors / TD. Gilligan, J. Seidenfeld, EM. Basch [et al.] // J.Clin.Oncol. – 2010. – 20. – P. 3388–404. https://doi.org/10.1200/JCO.2009.26.4481
Barlow L. Serum tumor markers in the evaluation of male germ cell tumors / L. Barlow, G. Badalato, J. McKiernan // Nat Rev Urol. – 2010. – 7 (11). – P. 610–7. https://doi.org/10.1038/nrurol.2010.166
Krege S. The role of tumour markers in diagnosis and management of testicular germ cell tumours / S. Krege, P. Alberts, A. Heidenreich // Urologe A. – 2011. – 3. – P. 313–21. https://doi.org/10.1007/s00120-010-2414-5
Ulbright TM. The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them / TM. Ulbright // Adv Anat Pathol. – 2008. – 1. – P. 18–27. https://doi.org/10.1097/PAP.0b013e318159475d
Cleynen I. The HMGA proteins: a myriad of functions (Review) / I. Cleynen, W. Van de Ven // Int J Oncol. – 2008. – 2. – P. 289–305. http://dx.doi.org/10.3892/ijo.32.2.289
Pallante P. High mobility group a proteins as tumor markers / P. Pallante, R. Sepe, F. Puca [et al.] // Front Med. – 2015. – 2. – P. 15. https://doi.org/10.3389/fmed.2015.00015
Barbagallo F. Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas / F. Barbagallo, M. Paronetto, R. Franco [et al.] // J Pathol. – 2009. – 217 (3). – P. 431–41. https://doi.org/10.1002/path.2471
Looijenga L. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors / L. Looijenga, H. Stoop, H. de Leeuw [et al.] // Cancer Res. – 2003. – 63 (9). – P. 2244–50.
Gillis A. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis / A. Gillis, H. Stoop, K. Biermann [et al.] // Int J Androl. – 2011. – 34. e160–74. https://doi.org/10.1111/j.1365-2605.2011.01148.x
Dieckmann K. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours / K. Dieckmann, M. Spiekermann, T. Balks [et al.] // Br J Cancer. – 2012. – 10. – P. 1754–60. https://dx.doi.org/10.1038%2Fbjc.2012.469
Spiekermann M. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker / M. Spiekermann, G. Belge, N. Winter [et al.] // Andrology. – 2015. – 1. – P. 78–84. https://doi.org/10.1111/j.2047-2927.2014.00269.x
Rounge T. Profiling of the small RNA populations in human testicular germ cell tumors shows global loss of piRNAs / T. Rounge, K. Furu, R. Skotheim [et al.] // Mol Cancer. – 2015. – 14. – P. 153. https://doi.org/10.1186/s12943-015-0411-4
Syring I. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer / I. Syring, J. Bartels, S. Holdenrieder [et al.] // J Urol. – 2015. – 1. – P. 331–337. https://doi.org/10.1016/j.juro.2014.07.010
Catto J. MicroRNA in prostate, bladder, and kidney cancer: a systematic review / J. Catto, A. Alcaraz, A. Bjartell [et al.] // Eur Urol. – 2011. – 5. – P. 671–81. https://doi.org/10.1016/j.eururo.2011.01.044
Gillis A. Targeted serum miRNA(TSmiR) test for diagnosis and follow-up of testicular germ cell cancer patients: a proof of principle / A. Gillis, M. Rijlaarsdam, R. Eini [et al.] // Mol Oncol. – 2013. – 6. – P. 1083–92. https://doi.org/10.1016/j.molonc.2013.08.002
Palmer R. Children’s Cancer and Leukaemia Group. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets / R. Palmer, M. Murray, H. Saini [et al.] // Cancer Res. – 2010. – 7. – P. 2911–23. https://dx.doi.org/10.1158%2F0008-5472.CAN-09-3301
Ruf C. Small RNAs in the peripheral blood discriminate metastasized from nonmetastasized seminoma / C. Ruf, D. Dinger, M. Port [et al.] // Mol Cancer. – 2014. – 6. – 13. – P. 47. https://doi.org/10.1186/1476-4598-13-47
Chieffi P. Recent advances in molecular and cell biology of testicular germcell tumors / P. Chieffi // Int Rev Cell Mol Biol. – 2014. – 312. – P. 79–100. https://doi.org/10.1016/B978-0-12-800178-3.00003-8
Chieffi P. An up-date on newly discovered immunohistochemical biomarkers for the diagnosis of human testicular germ cell tumors / P. Chieffi, S. Chieffi // Histol Histopathol. – 2014. – 29 (8). – P. 999–1006 https://doi.org/10.14670/HH-29.999